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Antigenic differences among strains of influenza A  virus have been demon- 
strated by means of cross neutralization, immunity (1-7), agglutination  inhibi- 
tion  (8-12), and complement fixation (13)  tests.  These  studies indicate that 
there  are antigens  which  are  common to all of the  strains,  but  that  certain 
strains contain very different proportions of the antigenic components.  The 
present paper reports a  study of the antigenic composition of several strains of 
influenza  A  virus  by means of specific antibody absorption  tests.  Evidence 
will  be  presented  which  indicates  that  each  contains  qualitatively  distinct 
antigens. 
Antibody  absorption  tests  with  influenza  virus  have  been  reported  by several 
groups of workers.  Smorodintsev et al. (14) showed the relationship of the Leningrad 
strain of influenza  virus to the W.S. virus by absorbing neutralizing antibodies from 
a  W.S.  immune serum with a  mouse lung emulsion containing the Leningrad strain 
of virus.  Stuart-Harris et al.  (4)  could demonstrate absorption of antibody from a 
W.S. serum with homologous virus suspensions  only if the serum was first diluted al- 
most to the  limit of  its  efficacy.  Burnet  (2)  found  that serum  antibody demon- 
strable by the  egg membrane technique  could be  readily absorbed with  influenza 
virus, but usually no significant reduction was apparent by mouse titration.  Titrated 
by the egg membrane technique strains Melbourne, Philadelphia, and PR8 absorbed 
antibody from a  Melbourne antiserum,  whereas strains swine,  W.S.,  Moscow,  and 
Leningrad  showed  no  detectable  absorption.  Smith  and  Andrewes  (7)  reported 
absorption of W.S. serum antibody (horse, ferret, or rabbit sera) with the very potent 
W.S.  virus.  They were much less successful  with swine,  Talmey, Philadelphia,  or 
Bur. viruses and their homologous  rabbit or ferret antisera.  They did succeed, how- 
ever, in absorbing the antibodies against W.S. virus contained in Talmey, Philadelphia, 
and Bur. antisera with W.S.  virus. 
Methods 
Virus Suspensions.--Six strains of influenza A virus--PR8 (15), W.S.  (16), swine 1, 
Talmey, Christie  (7), and Dra. 2  (8)--and the Lee strain  (17) of influenza  B  virus 
were used in this work.  Suspensions of the virus strains were prepared by inoculating 
infected allantoic fluid in dilutions of 10  -8 or 10  -4 into the allantoic sac of 11 day old 
1 Strain  1976 obtained from Dr.  R.  E.  Shope. 
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chick embryos.  Mter incubation  at 37°C. for 48 hours, the eggs were placed at 4°C. 
overnight, and blood-free allantoic fluid was removed the following morning.  The 
fluids were cleared by a short centrffugation at 2,000 R.P.u. and stored at -  72°C. until 
used. 
Immune Sera.--Ferrets were inoculated intranasally  with a 10  -3 dilution  of allantoic 
suspensions of  the virus strains.  The animals were bled before inoculation and 2 
weeks after infection.  Human sera were obtained before and 2 weeks after infection 
or following vaccination.  The sera were stored at 4°C., and all were inactivated at 
56°C.  for 30  minutes before use  in the  tests. 
Absorption  of Antibody.--Immune serum diluted 1:16 to  1:32 with 0.9 per cent 
saline solution buffered at pH 6.9 with ~/50 phosphate, was mixed with undiluted 
allantoic fluid suspensions of virus or with concentrated virus suspensions obtained 
from allantoic fluid by high-speed centrifugation or by the red cell adsorption and 
elution technique (18).  The serum-virus mixtures were incubated at 37°C. for 30 
minutes and kept at 4°C. overnight.  They were then spun at 11,000 R.P.M. for 30 
minutes in an angle centrifuge to  remove most of  the virus, and the supernatant 
fluid was filtered through graded collodion membranes of 600 m# average pore diam- 
eter.  The membranes were  provided by Dr. J. H. Bauer of this laboratory.  The 
filtrates were finally cleared of  virus by passage through  100 m/z membranes.  As 
previously reported  (19),  filtrates obtained in this way contained no virus demon- 
strable by infectivity or agglutination tests.  Control mixtures of immune serum and 
buffered saline were concurrently treated in identical manner.  The control mixtures 
showed  a  small loss in serum antibody as a  result of the filtration, but the decrease 
was usually not more than 15 per cent of the original concentration.  The absorbed 
sera were kept at  -72°C. until used.  They were  then tested for residual antibody 
by means of  the  standard agglutination inhibition and complement fixation tests. 
In some experiments the mouse neutralization test was also done. 
Agglutination  Inhibition  Test.--Serum  antibody titrations by this  method  were 
made by a  standard technique already fully described (20).  A final concentration 
of 4 agglutinating units of virus was used in each test by performing preliminary 
hemagglutinin titrations with the same chicken red blood cells to be employed in the 
final test.  The virus was again titrated in the final test, and any deviation from 4 
units was compensated by correcting the final antibody titers obtained as described 
by Hirst (8).  The titers are expressed  as the reciprocal of the serum dilution (final 
concentration after adding all reagents) inhibiting  agglutination of 50 per cent of the 
red cells under the standard conditions of the test. 
Complement Fixation  Test.--Dilutions of  serum were  mixed with 2 fifty per cent 
hemolytic units of complement (titrated in the presence of antigen used in the test) 
and allantoic fluid virus suspensions in dilution of  1:5 as antigens, according to a 
technique previously described (13).  The titers are expressed  as the reciprocal of the 
initial serum dilution producing hemolysis of  50 per cent of  the sheep red cells as 
recorded by a photoelectric densitometer.  The final dilution of serum after addition 
of antigen and hemolytic system would be 6  times that given. 
Neutralization  Test.--Serum dilutions in steps of  10  -0.5 were mixed with allantoic 
fluid containing about 31 M. L. D. of virus.  All dilutions were made with 10 per cent WILLIAM F.  ]~RIEDEWALD  635 
horse serum broth.  The mixtures were kept at 4°C.  overnight  2 and  the following 
day 0.05 cc. samples of each dilution were instilled intranasally into groups of 6 albino 
Swiss mice under light ether anesthesia.  The 50 per cent mortality titer was cal- 
culated from the number of mice which died within  10 days after inoculation. 
EXPERIMENTAL 
Absorption of Homologous Ferret Serum  Antibodies with Influenza  Virus.- 
In a  first experiment to learn whether  serum  antibody could be removed by 
absorption  with  allantoic fluid  containing  influenza virus,  a  PR8  and  a  Lee 
ferret serum in dilution of 1 : 20 was mixed in equal parts with buffer solution, 
PR8, Lee, and normal allantoic fluids.  The mixtures were incubated, centri- 
fuged, and filtered as described under Methods.  Fig.  1 shows the amount of 
residual antibody as determined by the agglutination inhibition test in which 
the homologous virus strain was  used on  the  test virus.  The  PR8  allantoic 
fluid absorbed 79 per cent of the antibody in the PR8 ferret serum, whereas the 
Lee  and  normal  allantoic fluids failed  to  remove  any  detectable amount  of 
antibody.  Conversely, only the Lee allantoic fluid absorbed antibody (85 per 
cent)  from the Lee ferret serum. 
To demonstrate further the specific absorption of antibodieswith influenza 
virus, PR8, W.S., and swine-ferret antisera were absorbed with large amounts 
of  PR8,  W.S.,  swine,  and  Lee  viruses  concentrated  from  allantoic fluid  by 
high-speed centrifugation. 
Forty-five cc. portions of PR8, W.S., swine, Lee, and normal allantoie fluids were 
centrifuged at 30,000 R.P.M. for 45 minutes in the vacuum centrifuge, and the super- 
natant fluids were discarded.  The pellets of sediment, which contained most of the 
virus, were resuspended in 15 cc. aliquots of PR8, W.S., and swine-ferret sera, all in 
dilution of 1:32.  The mixtures were incubated, centrifuged, and filtered as described 
under Methods.  A second absorption of a portion of the sera (8 cc.) was carried out 
as before with the sediment from 45  cc. of the various allantoic fluids.  All of the 
filtrates were then tested for residual antibody by means of neutralization, agglutina- 
tion  inhibition, and  complement fixation tests.  The  serum  specimens were  tested 
against the homologous virus in each instance. 
2 In unpublished experiments in collaboration with Dr. G. K. Hirst it was found 
that the neutralization of allantoic fluid suspensions of influenza virus with immune 
serum was more complete when the mixtures were left overnight at 4°C. than after 
incubation at 37°C. for 1 hour.  With short incubation at 37°C. a given serum became 
less efficient in its capacity to neutralize virus as it was used in progressively greater 
dilution, just as reported by Horsfall in tests with mouse lung extracts (21).  When 
the same serum-virus mixtures were kept overnight at 4°C., this effect of dilution on 
the combining capacity of antibody was greatly reduced, and the relation between 
the quantity of virus neutralized and quantity of serum used closely approximated 
one of multiple proportions over a  wide range of virus and  serum  concentrations. 636  ANTIGENIC  COMPOSITION  OF INFLUENZA  VIRUS 
The results of the neutralization test are shown in Fig. 2.  In general it will 
be seen that the antibody in each serum was completely removed only by the 
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FIG.  1.  Agglutination  inhibition  tests  with  PR8  and  Lee  ferret  antisera  after 
:absorption with normal, PR8, and Lee allantoic fluid.  The amount of antibody re- 
maining after absorption is shown in terms of per cent of the antibody content of the 
control serum buffer mixtures (see text),  The PR8 serum was tested for inhibition 
of agglutination of PR8 virus and the Lee serum was tested against Lee virus. 
1st absorption  2nd absox~ption 
with  with 
Te~t 
C°ntv°l]~B  W.5. 5w.  lee  ~r~]~8  ~t.5.  5w. l~e  ~erurn  ~ti*~u  s 
•  t.0  4.0 
3.5  3.5 
?R8  PRB  ~3.01_  •  3.0 
'~  zsI-  •  z.5 
rzo~  z  o 
.  3.0 
W.5.  v/.B.  ~ 2  2.5 
2£  2.0 
~].5  1.5 
:  3.o 
~wine  ~wine  Z.5  Z.5 
2.0i  ~.0 
1.5  1.5 
FIG. 2 Neutralization tests with ferret antisera absorbed twice with the sediment 
from normal  (control)  and  virus-infected  allantoic  fluids  (see  text).  The  antisera 
were tested for capacity to neutralize about 31 ~r. T.. D. of the homologous virus. 
homologous virus strain, even though 2 absorptions were carried out with large 
amounts  of heterologous virus  strains.  For example, most of the  W.S. anti- 
bodies were removed on the first absorption with W.S. virus, whereas PR8 virus 
caused only partial absorption and the swine and Lee viruses had no detectable WILL~  ,]~.  ]~EIED~WAI~D  637 
effect on the antibody level.  The second absorption:with W.S. virus removed 
all of the remaining antibody from the W.S: serum, but the heterologous strains 
had no further detectable effect.  The PR8 virus removed all of the  detectable 
antibody from  the  PR8  serum  on  the  first  absorption.  The  agglutination 
inhibition and complement fixation tests gave results similar to those obtained 
with the neutralization test.  These tests are more sensitive to small changes in 
antibody concentration than the neutralization test, and partial absorption of 
antibody with the heterologous A strains was more apparent as shown later in 
Fig. 4.  However, the significance of small changes in antibody level following 
absorption is somewhat uncertain because of the necessity of using a  different 
collodion membrane for filtration of each serum-virus mixture.  Nevertheless, 
the failure of the second absorption with heterologous virus strains to remove 
further  antibody from the  ferret  sera  strongly  suggests  complete absence of 
virus antigen  related  to the unabsorbed antibody. 
Manifestly  the  absorption  tests  revealed  a  high  degree  of specificity and 
qualitative individuality of the PR8, W.S., and swine strains of influenza virus. 
Each virus completely absorbed the neutralizing, agglutination-inhibiting, and 
complement-fixing antibodies from the homologous ferret serum, but 2 absorp- 
tions with large amounts of virus failed to remove the antibodies in heterologous 
sera. 
Quantitative  Relations  of  the Absorption  of Neutralizing,  Agglutination-In- 
hibiting,  and Complement-Fixing  Antibodies.--Evidence  already obtained  has 
indicated  that  the  infective  activity and  the  property  of influenza  virus  to 
agglutinate  red  blood  cells are closely associated  (8,  18).  The complement- 
fixing antigen has been found to consist of a fraction intimately associated with 
the virus particle and another fraction of a smaller size which is separable from 
the virus particle--the so called soluble antigen (13).  It seemed possible that 
absorption of the antibodies directed against influenza virus suspensions might 
throw further light on the relationship of these properties of the virus particle. 
In  the next experiment a  serum  from a  ferret  convalescent  from PR8  virus 
infection was absorbed with  varying amounts  of PR8  virus obtained by the 
red cell adsorption and elution  technique. 
Three hundred cc. of PR8 allantoic fluid was mixed with 3 cc. of chicken  red cells 
which  had been washed 3 times and packed by light centrifugation.  The mixture 
was kept at 4°C. for 30 minutes to permit adsorption of the virus, and the cells were 
then removed by centrifugation.  The cells were resuspended  in  100 cc. of buffered 
saline  solution,  and elution of the virus was carried out  at  37°C. for 2 hours.  The 
red  cells were  then discarded  after centrifugation.  One  hundred  cc. of the  eluate 
was again adsorbed with 1 per cent red cells and the virus eluted into 10 cc. of buffered 
saline  solution as before.  The original allantoic fluid had an agglutination  titer of 
1:479 and an infectivity titer of 10  -6'°, whereas the final eluate had an agglutination 
titer of 1:5420  and infectivity titer of 10  -s'°.  These findings  indicate that only 38 
per cent of the original hemagglutinin and 26 per cent of the infectivity were recovered 638  ANTIGENIC  COMPOSITION  O~'  INFLUENZA  VIRUS 
by this method.  The loss in virus could not  be accounted for in the  supernatant 
fluids following adsorption and hence it appeared to be due to failure of much of the 
virus to elute from the red cells. 
Four cc. aliquots of a  PR8 ferret serum in dilution  of  1:16 was mixed in  equal 
parts with the above eluate undiluted  and in dilutions of 1:2,  1:4,  1:8,  and 1:16. 
The mixtures were incubated, centrifuged,  and filtered as in the preceding experiment. 
In addition each filtrate was again passed through another 100 m# membrane.  The 
filtrates were then tested for residual antibody by means of neutralization, agglutina- 
100 
\\~k  o Complement ~ixat~on 
90  ~\ \  o A991utinctio  n inhibition 
Neutralization 
•  ~  80 
.~  70 
0  60 
50 
lC 
Contr~l~  1:16  1:8  1:t  l:Z  1:1 
~Dilutton o~vi~,u~ ~u~pen~ion 
u~ed  to absorb ~e~urn 
FIG. 3.  Absorption of a PR8 ferret serum with varying amounts of a concentrated 
suspension  of PR8 virus prepared by the red cell adsorption and elution technique 
(see text). 
tion, and complement fixation tests.  Each test was done in duplicate at different 
times. 
Fig. 3 shows the results of the experiment in terms of per cent of the concen- 
tration of antibody in the control serum mixture.  The amount of antibody 
remaining in the serum, as determined by all 3  tests, varied inversely as the 
concentration  of virus used for absorption.  A  given concentration  of virus, 
however,  removed  more  neutralizing  antibody  than  either  agglutination-in- 
hibiting or complement-fixing antibodies.  This was particularly striking when 
the dilute concentration of virus (1:16)  was used for absorption--80 per cent 
of the neutralizing antibody was removed, whereas 50 per cent of the agglutina- 
tion-inhibiting and only 25  per cent of the complement-fixing antibody were WILLIAM  F.  I~RIEDEWALD  639 
absorbed by the virus.  These differences  were somewhat smaller when more 
concentrated virus was used for absorption.  The possible significance of these 
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FIC. 4,  Absorption of homologous  and heterologous antibodies from PR8, Christie, 
and W.S. ferret antisera with various virus strains. 
differences  in the  rate of absorption  of  the  antibodies detectable  by  the  3 
tests will be  considered  in  the  discussion. 
Absorption of Homologous and Heterologous Ferret Serum Antibodies.--The 
preceding experiments have dealt primarily with absorption of the antibodies 
in ferret sera which react with the homologous virus strain  used to elicit the 640  ANTIGENIC  COMPOSITION  OF INFLUENZA  VIRUS 
antibodies.  AbsOrption  of the  antibodies  in  these  sera  which  react  with 
heterologous  virus  strains was next investigated. 
PR8, Christie,  and W.S. ferret antisera were diluted to 1:16 with buffered saline. 
Ten cc. aliquots were mixed with the virus sediment, obtained by centrifugation at 
13,000 R.P.~t. for 45' minutes, from W.S., swine, Talmey, and Christie allantoic fluids. 
The mixtures were incubated, centrifuged, and filtered as in the preceding experiments. 
A  Control  serum  sample containing  buffered saline  instead  of virus sediment  was 
treated  in  identical  manner.  The filtrates were  then  tested for residual antibody 
by means of agglutination inhibition and complement fixation tests using PR8, W.S., 
swine, Talmey, and Christie allantoic fluids as the test viruses. 
The results of the complement fixation and agglutination tests were similar, 
and hence only the latter are shown in Fig. 4.  In each instance the antibodies 
in  the  PR8,  Christie,  and  W.S.  sera  were  completely absorbed  only by  the 
homologous virus  strain.  PR8  virus  absorbed  all  of the  heterologous  anti- 
bodies from the  Christie  and  W.S.  sera but failed to remove completely the 
homologous antibodies.  The  other  virus strains  differed from PR8  virus  in 
that each absorbed completely only those heterologous antibodies which reacted 
with  the particular  strain used for absorption.  A  possible exception to  this 
were the swine antibodies which were absorbed by all of the virus strains, but 
the  initial  titers were so low in  each  serum  that  the  extent  of reduction  by 
absorption  could  not  be determined. 
The experiment illustrates the complex antigenic composition of the influenza 
virus  strains.  Absorption  of a  serum with  large  amounts  of a  heterologous 
virus usually left antibodies which reacted with several other heterologous as 
well as the homologous virus strain.  PR8 virus appeared to have the broadest 
antigenic pattern of the strains tested, yet it lacked certain components pos- 
sessed by the  Christie  and  W.S.  viruses. 
Absorption  Tests with Human  Sera 
It has been repeatedly shown that the specificity of strains of influenza virus 
is much less apparent in their cross reactions with human sera than with animal 
sera obtained after a single injection of a strain of virus.  Horsfall and Rickard 
(22)  could demonstrate no strain specificity in  the  sera of 5  persons infected 
with influenza A.  Bodily and Eaton  (23), however, studied a  larger number 
of sera from vaccinated and convalescent  persons and found a  limited amount 
of antibody specificity for strains of influenza virus.  It was of interest, there- 
fore, to utilize absorption tests in the study of the specificity of the antibody 
response of human beings following vaccination and following infection  with 
influenza  virus. 
Postvaccination Sera.--Human sera taken before and 2 weeks after vaccina- 
tion with influenza virus were available for study.  The vaccine used consisted TABLE I 
Human Serum A ntibody  Response  to Vaccination  with PR8 Virus 
Patient 
No.  Test virus strain 
PR8 
Christie 
W.S. 
Talmey 
Swine 
PR8 
Christie 
W.S. 
Talmey 
Swine 
PR8 
Christie 
W.S. 
Talmey 
Swine 
PR8 
Christie 
W.S. 
Talmey 
Swine 
PR8 
Christie 
W.S. 
Talmey 
Swine 
PR8 
Christie 
W.S. 
Talmey 
Swine 
PR8 
Christie 
W.S. 
Talmey 
Swine 
PR8 
Christie 
W.S. 
Talmey 
Swine 
Serum antibody titer* 
Agglutination inhibition 
Pre-  Post- 
135  3,520 
156  2,684 
124  2,164 
66  1,053 
97  718 
102  1,845 
223  1,092 
100  863 
76  651 
167  359 
90  2,408 
97  1,614 
70  1,060 
14  695 
32  236 
310  2,864 
312  1,337 
187  568 
100  1,388 
254  441 
178  2,200 
136  1,092 
100  530 
26  608 
73  507 
166  1,336 
146  670 
132  1,060 
32  282 
254  668 
Complement fixation 
Pre-  Post- 
14  388 
16  223 
15  194 
15  208 
13  120 
11 
14 
12 
16 
23 
28 
26 
22 
28 
42 
15 
13 
13 
11 
10 
14 
12 
15 
11 
28 
208 
128 
42 
147 
104 
72  1,080 
78  545 
38  748 
25  151 
84  312 
72  940 
78  545 
47  326 
13  246 
39  118 
223 
112 
60 
158 
24 
388 
128 
60 
338 
64 
223 
91 
60 
194 
97 
120 
28 
91 
49 
104 
104 
32 
74 
49 
39 
8  97 
11  22 
8  24 
7  64 
?  16 
Antibody rises 
Aggluti-  Corn- 
nation  plement 
~hibition  fixation 
3 ,~5  374 
2,528  207 
2,040  179 
987  193 
621  107 
1,743  197 
869  114 
763  30 
575  131 
192  81 
2,818  216 
1,517  108 
990  55 
681  154 
204  21 
2,5~  360 
1,025  102 
381  38 
1,288  310 
187  22 
2,0~2  2O8 
956  78 
430  47 
582  183 
434  87 
1,170  106 
524  16 
828  76 
250  38 
414  76 
1,0O8  97 
467  26 
710  68 
126  43 
228  32 
868  89 
467  11 
279  16 
233  57 
79  9 
* Titers are expressed as the reciprocal of the serum dilution end point (see iVfethoch). 
:~ Obtained by subtracting  the pre- from the postvaceination titer. 
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of formolinized PR8 and Lee influenza viruses which had been concentrated from 
freshly thawed  allantoic  fluid according to  the  method described by  Hirst, 
Rickard, and Whitman (24).  Sera from 8 patients were taken at random and 
tested for antibody response by means of cross agglutination  inhibition and 
complement  fixation tests  against  PR8,  Christie,  W.S.,  Talmey, and  swine 
viruses.  The results  are  summarized  in  Table I.  It  will  be  seen  that  the 
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"Vi~u~  jtr,  ain  Agqlutinat.ion  Co~nplemen~ 
~eptio~  Test vinu~  Te~t ~i~u~ 
~urn  Pl~ CI~ Tel. W.~. ~w.  PR8 ~  ~1 ~.~  ~. 
20e8].-at7,  r-,  ~"  r  ~.,  -'IS!Z 
lO~t.I  i  r-,  :  :  '  r7  -~Z56 
PR8  51ZI-'  ~';  r-.  '  '  J  r']  1  i  !  i  I  '  i  , 
:I  "  ....  256 I-  ,  ,  ,  ,  i~,,  :  ::  ',  :' 
,.  ,  ,,,  ,,  ,:lS~  '  "  .1.6 
4~6r  7 
20481-  r-~  r-~  ~  r  "  "  ~..  751~ 
I  ¢  I  I  r'-~  ioz4~  .....  ~  ~,  r,  i  ! 
I-,  ,  ,  ,  ~-~  -I~  I  '  "  "  i 
C~i~e  51~I-'~'  ,  ,  ,  ,  ,  '  "-~  4  I-'  '  ,  ',  ,  ,  r-,4128 
256  '  ~  '  '  :  ',  '  '  '  '  '  '  ~  '  '  J~'  i ~ lIE '  !  i4,  , ,  , ,  ~I  ....  ' ' ' ',~" 
1~~  I-II  ,  '  m  •  ',  ,q  52 
'  "  "  16 
~o?sr  7 
=so~,,,,  _[  [Z  ,,,,:~.,  -I~s 
,,,1,,11 
40% 
~o-I-H,':,-,~:  -I  I:,,  ,  ,,,~-,  :]~ 
2048~  r'l,  r-,  ~  r  r-]  r7  r-~  "151~ 
m~4k~  '--'  ,-,  r7  -I  ~-,.  =-  ,,  ,.,  ~z~s 
~e£,'rle  ~J.21-I  II  '  ,  r'~-I  ,  ,  r-~  8  ~B  "  i  l  ,  ,  I  l  l  l  l  l  J2 
~"lo. 5. Abso~tion of a  human serum  obtained 2 weeks after vaccination with 
PR8 virus. 
vaccine elicited a rise in serum antibodies against all of the virus strains tested. 
The antibody rise in each individual, obtained by subtracting the pre- from the 
postvaccination titers, was  consistently highest against  PR8 virus,  although 
the amount of antibody elicited by some of the other strains was only slightly 
less in some instances.  The cross tests, therefore, indicated a  limited degree 
of specificity in the  total antibody response to vaccination.  In general  the 
results obtained by the agglutination inhibition and the complement fixation 
test showed a  close parallelism. WILLIAM  F.  FRIEDEWALD  643 
The postvaccination  serum from patient  1  (Table  I)  was selected  for ab- 
sorption because of the small differences in antibody titer against PR8, Christie, 
and W.S. viruses.  The serum in dilution of 1:32 was absorbed with the sedi- 
mented  virus  from 45  cc.  lots  of  PR8,  Christie,  Talmey,  W.S.,  and  swine 
allantoic fluids as described in the preceding experiment.  The results of the 
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FIa. 6.  Absorption of a human serum obtained 2 weeks after an attack of influenza. 
The vires strain Dra. 2 was isolated from the patient during the acute illness. 
experiment (Fig. 5) were similar to those obtained on absorption of PR8 ferret 
serum (Fig. 4).  PR8 virus removed all of the antibodies which reacted with 
the  homologous and  the  heterologous  virus  strains,  whereas  the  other  virus 
strains absorbed only the antibodies directed against the  virus used for absorp- 
tion  and  in  most  instances  the  antibodies  which  reacted  with  swine  virus. 
Similar results were obtained on absorption of the postvaccination serum from 
patient 4  (Table I), and the findings need not be given in  detail. 
Convalescent Serum.--In  the  next  experiment  a  serum  obtained  from  a 644  ANTIGENIC  COMPOSITION  OF INFLUENZA  VIRUS 
patient convalescing from an attack of influenza was absorbed as described in 
the preceding experiment.  In addition the virus strain  (Dra.  2), which was 
obtained from the patient's throat washing during the acute illness,  was also 
used for absorption of the serum.  Fig. 6 shows the result of the test.  The 
virus strain isolated from the patient (Dra. 2) and PR8 virus absorbed all of 
the antibodies against the test viruses employed.  Christie, W.S., and swine 
viruses absorbed only the swine antibodies and the antibodies which reacted 
with the virus used for absorption.  Although the PR8 and Dra. 2 virus strains 
are closely related, as shown in this experiment, further tests with ferret antisera 
indicated minor antigenic differences. 
DISCUSSION 
The foregoing experiments clearly show that antibody absorption tests pro- 
vide a valuable tool for studying the antigenic composition of influenza viruses. 
While much more remains to be done to obtain a clear picture of the complex 
antigenic interrelationship of the different virus strains, some new facts have 
already emerged which permit a more precise evaluation of this problem.  Both 
by absorption and by the previously employed techniques the influenza A and 
B groups of viruses stand out as distinct entities with no overlapping or related 
antigens.  In  respect  to  the  antigenic  comparisons  within  the  influenza A 
group, the cross reactions between the virus strains previously reported brought 
out the fact that the quantitative distribution of antigens common to various 
strains was more or less different.  On the basis of cross absorption tests we may 
now further conclude that there are qualitative antigenic distinctions as well. 
The PR8 virus strain, for example, contains an antigen (or antigens) which is 
not possessed by the  Christie,  Talmey, W.S.,  or swine virus  strains. 
Whether or not the distinctive antibodies, demonstrable after 1 or 2 absorp- 
tions of a serum with a heterologous virus, represent the response to a  "strain 
specific" antigen (i.e.,  an antigen possessed only by the particular strain) cannot 
be deduced from the available data.  The fact that absorption of a serum with 
large amounts of a  heterologous virus usually left polyvalent antibody (i.e., 
able to react with other heterologous as well as the homologous strains) would 
suggest that at least a portion of the residual unabsorbed antibody may have 
been produced by antigens common to other virus strains.  PR8 virus provided 
an exception for it absorbed all of the heterologous antibodies from Christie 
and W.S. antisera and left only those which reacted with the respective homolo- 
gous strains.  In order to demonstrate true strain specificity of these unab- 
sorbed  antibodies,  however,  it  would be  necessary to  show  that  successive 
absorptions with large amounts of a  number of heterologous strains failed to 
remove completely the antibodies directed against the homologous strain. 
Smith and Andrewes  (7)  found that 4  strains of influenza A virus (W.S., 
Christie, Talmey, and Gatenby) exhibited large quantitative differences in the 
homologous and  heterologous antibody response  demonstrable by means of WILLIAM  F.  FRIEDEWALD  645 
cross neutralization tests.  PR8 virus was found to be an "intermediate" strain 
reacting in high titer with both  Christie and Talmey viruses.  The  present 
absorption tests revealed a higher degree of specificity and individuality of the 
virus strains than could have been anticipated by their cross reactions.  PR8 
and Christie viruses, for example, appear  to be very closely related in cross 
tests  (neutralization,  agglutination inhibition,  complement fixation)  yet ab- 
sorption tests clearly show that each contains antigens which are not shared 
by the other.  The absorption tests confirmed the finding of Smith and An- 
drewes  (7)  that  the  Christie  and  Talmey strains  are  antigenically distinct, 
although Burnet and Clark  (9)  could demonstrate no difference between the 
2  strains. 
The specificity of the PR8 virus strain was equally manifest in absorption 
tests with ferret sera and with human sera following vaccination.  The latter 
finding is particularly significant because human sera show much less difference 
in  antibody levels  against  homologous and  heterologous virus  strains  than 
animal sera.  If the quality  of the antibodies called forth by different virus 
strains proved to be an important factor in immunity to human infection with 
influenza virus, it would seem desirable to classify influenza virus strains on the 
basis of the number and kind of available antigenic components.  Of the virus 
strains studied in the present work  PR8 virus would appear to be the  strain 
of choice in evoking immunity, for it has the broadest range of specific antigenic 
components (Figs. 4 and 5) and elicits high titers of antibodies against a variety 
of different strains. 
The  absorption  tests  provide  further  evidence  that  the  hemagglutinin, 
complement-fixing antigen, and infective activity of influenza virus are closely 
related properties of the virus particle per se, though not necessarily identical. 
A suspension of PR8 virus particles, obtained by the  red cell adsorption and 
elution  technique,  concurrently absorbed  the  neutralizing,  agglutination-in- 
hibiting, and complement-fixing antibodies from a  PR8 ferret serum (Fig. 3), 
and the amount of antibody removed in each instance was inversely propor- 
tional to the concentration of virus used for absorption.  However, a  greater 
proportion of neutralizing antibodies was absorbed by a  given concentration 
of virus than either agglutination-inhibiting or complement-fixing antibodies. 
It seems possible that the neutralizing antibodies are elicited chiefly by the 
surface components of the intact virus particle and hence are  more readily 
absorbed by a  suspension of virus particles than the agglutination-inhibiting 
or complement-fixing antibodies which appear to be directed not only against 
the primary virus particle but also against disintegration products of the virus 
(19). 
S~AR¥ 
A study of the PR8, Christie, Talmey, W.S., and swine strains of influenza 
A virus by means of antibody absorption tests revealed the following findings: 
1.  Serum antibody could be specifically absorbed with anantoic fluid contain- 646  ANTIGENIC  COMPOSITION  OF  INFLUENZA  VIRUS 
ing influenza virus or, more effectively, with concentrated suspensions of virus 
obtained from allantoic  fluid by high-speed  centrifugation  or by the red  cell 
adsorption  and  elution  technique.  Normal  allantoic  fluid,  or  the  centrifu- 
galized  sediment  therefrom,  failed  to  absorb antibodies.  Influenza  B  virus 
(Lee)  caused  no  detectable  absorption  of  antibody  from  antisera  directed 
against  influenza  A  virus strains,  but it specifically absorbed antibody from 
Lee antisem. 
2.  The  neutralizing,  agglutination-inhibiting,  and  complement-fixing  anti- 
bodies in  ferret  antisera  were  completely absorbed  only by the  homologous 
virus strain,  even though 2 absorptions were carried out with large amounts 
of heterologous  virus  strains. 
3.  PR8  virus  appeared  to  have  the  broadest  range  of  specific antigenic 
components for it completely absorbed the heterologous antibodies in Christie 
and W.S. antisera and left only those antibodies which reacted with the respec- 
tive  homologous  strains.  The  other  virus  strains  (Christie,  Talmey,  W.S., 
swine)  were  more  specific in  the  absorption  of heterologous  antibodies  and 
completely removed only those antibodies  which  reacted with  the absorbing 
virus. 
4.  The absorption tests revealed a higher degree of specificity and individu- 
ality of the virus strains than  the various cross reactions previously reported. 
The  strain  specificity of PR8 virus was equally manifest  in absorption  tests 
with  ferret  sera  and  with  human  sera  following vaccination. 
5.  The  amount  of homologous antibody  remaining  in a  PR8 ferret  serum 
after absorption with PR8 virus, obained by the red cell adsorption  and elution 
method,  varied  inversely as  the  concentration  of virus  used for  absorption. 
A  given  concentration  of virus,  however,  absorbed  a  greater  percentage  of 
neutralizing  antibodies  than  either  agglutination-inhibiting  or  complement- 
fixing antibodies. 
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